Upload
annbe-barte
View
224
Download
0
Embed Size (px)
Citation preview
7/30/2019 MF3 - Ischemic Heart Disease
1/28
ISCHEMIC HEART DISEASE
LORRAINE CAUSING
7/30/2019 MF3 - Ischemic Heart Disease
2/28
Is a condition in which there is an inadequatesupply of blood and oxygen to a portion to the
myocardium
Most common cause: atherosclerosis
7/30/2019 MF3 - Ischemic Heart Disease
3/28
epidemiology
In U.S : 13 million IHD
> 6 million angina pectoris
> 7 million - MI
In U.S and western Europe:
IHD is growing among low-income groups
7/30/2019 MF3 - Ischemic Heart Disease
4/28
Risk factor:
obesity
insulin resistance
type 2 diabetes mellitus
7/30/2019 MF3 - Ischemic Heart Disease
5/28
7/30/2019 MF3 - Ischemic Heart Disease
6/28
CORONARY ATHEROSCLEROSIS
Major sites :
epicardial coronary arteries
Major risk factors :
high plasma low-density lipoprotein (LDL)
low plasma high-density lipoprotein (HDL)
cigarette smoking
hypertension
diabetes mellitus
7/30/2019 MF3 - Ischemic Heart Disease
7/28
Segmental narrowing of coronary arteries is
caused commonly by the formation of plaque
7/30/2019 MF3 - Ischemic Heart Disease
8/28
Effects of ischemia
Transient LV failure
Mitral regurgitation occurs if papillary muscle
apparatus is involved
* When ischemia is transient, it is associated withangina pectoris
* When prolonged, it can lead to myocardial necrosis
and scarring with or without MI
7/30/2019 MF3 - Ischemic Heart Disease
9/28
ASYMPTOMATIC VS. SYMPTOMATIC IHD
Asymptomatic phase
cardiomegaly
heart failure
* Ischemic cardiomyopathy
Symptomatic phase
chest discomfort
7/30/2019 MF3 - Ischemic Heart Disease
10/28
STABLE ANGINA PECTORIS
Due to transient myocardial ischemia
Men : 50 yrs. and older
Women : 60 yrs. And older Chest discomfort
Last for 2-5 mins.
Radiate to either shoulder, arms, back,interscapular region,root of the neck, jaw,
teeth, and epigastrium
7/30/2019 MF3 - Ischemic Heart Disease
11/28
Caused by :
exertion
emotion
* And are relieved by rest , but may also occur at
rest and while the patient is in recumbent
7/30/2019 MF3 - Ischemic Heart Disease
12/28
Physical examination
Examination of fundi
- increased light reflex and arteriovenousnicking hypertension
Palpation- cardiac enlargement and abnormal
contraction
Auscultation- uncover arterial bruits, 3rd & 4th heart
sounds
7/30/2019 MF3 - Ischemic Heart Disease
13/28
Laboratory examination
Urine examination Blood examination
Chest x-ray
Electrocardiogram
- used to measure the rate and
regularity of heartbeats, sizeand position of chambers and
presence of any damage
7/30/2019 MF3 - Ischemic Heart Disease
14/28
Stress testing
Electrocardiographic
- test for both the diagnosis of IHD and
estimating the prognosis involves recording
the 12-lead ECG before, during and after
exercise, usually
on a treadmill
7/30/2019 MF3 - Ischemic Heart Disease
15/28
Cardiac imaging
two-dimentional echocardiography
stress echocardiography
cardiac magnetic cardiography
7/30/2019 MF3 - Ischemic Heart Disease
16/28
Prognosis
Principal prognostic indicators age
functional state of LV
location(s) and severity or coronary arterynarrowing
Severity or activity of myocardial ischemia
Patients with chest discomfort but normal LVfunction and normal coronary arteries haveexcellent prognosis
7/30/2019 MF3 - Ischemic Heart Disease
17/28
Treatment
Nitrates
- vasodilator, thereby reducing myocardialwall tension and oxygen requirements
- dilates coronary vessels; increased bloodflow in collateral vessels
- exerts antithrombotic activity
- improves exercise tolerance- nitroglycerine : most commonly
administered sublingually
7/30/2019 MF3 - Ischemic Heart Disease
18/28
Longacting nitrates
- not as effective as sublingual
nitroglycerine
isosorbate dinitrates or mononitrate
nitroglycerine ointment
sustained release transdermal patches
7/30/2019 MF3 - Ischemic Heart Disease
19/28
7/30/2019 MF3 - Ischemic Heart Disease
20/28
Beta adrenergic blockers
- inhibits the heart rate, arterial pressure,
and myocardial contractility
- therapeutic aims: relief of angina and
ischemia
- contraindications: Asthma
chronic lung disease
AV conduction disturbances
severe bradycardia
Raynauds phenomenon
history of mental illness
7/30/2019 MF3 - Ischemic Heart Disease
21/28
7/30/2019 MF3 - Ischemic Heart Disease
22/28
Calcium channel blockers
- coronary vasodilators
- reduce myocardial oxygen demands,contractility and arterial pressure
- indicated when beta blockers are
contraindicated, poorly tolerated, or
ineffective
7/30/2019 MF3 - Ischemic Heart Disease
23/28
7/30/2019 MF3 - Ischemic Heart Disease
24/28
Antiplatelet drugs
aspirin
clopidogrel
Other therapies angiotensin-converting enzyme ( ACE ) inhibitors
nonsteroidal anti-inflammatory drugs ( NSAIDs)
7/30/2019 MF3 - Ischemic Heart Disease
25/28
Coronary revascularization
Precutaneous Coronary Intervention
-involves balloon dilation usually
accompanied by coronary stenting
Coronary Artery Bypass Grafting
- anastomosis of one or both of the internal
mammary arteries or radial artery to the
coronary artery distal to the obstructive
lesion
7/30/2019 MF3 - Ischemic Heart Disease
26/28
7/30/2019 MF3 - Ischemic Heart Disease
27/28
OT management
Energy conservation techniques
Stress management
Weight reduction Physical activities
7/30/2019 MF3 - Ischemic Heart Disease
28/28
END